Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Are Peptides coming off of the FDA Category 2 list? A legal breakdown. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York